LIVE TV
ZEE Business
ZEE BUSINESS
हिंदी में पढ़ें  हिंदी में पढ़ें
Live TV
Live TV
  • Home
  • Budget 2021
  • Personal Finance
    • PPF
    • Mutual Funds
    • Income tax
    • EPFO
    • Income Tax Calculator
    • Personal Loan Calculator
    • Car Loan Calculator
    • Home Loan Calculator
    • SIP calculator
    • SWP Calculator
    • MF Returns Calculator
    • Lumpsum Calculator
  • India
    • Companies
    • Property
    • Startups
    • Uidai
  • Economy
    • Aviation
  • Tech
    • Mobiles
    • Apps
  • Auto
    • Cars
    • Bikes
  • Markets
    • Commodities
    • Currency
  • Jobs
  • Indian Railways
  • World
    • Economy
    • Politics
    • Markets
  • videos
  • photos
  • Authors
  • More ...
    • VIDEOS
    • PHOTOS

Read in App
Business News » World News

Novartis aims to beef up Alcon before possible 2019 spin off

  • Twitter
  • Facebook
  • Linkedin
  • whatapp
  • View in App
Updated: Tue, Oct 24, 2017
02:37 pm
Reuters
RELATED NEWS
Expert Views: BIG! India's retail inflation eases to 4.59% in December Expert Views: BIG! India's retail inflation eases to 4.59% in December
Budget 2021 Expectations – HOME BUYERS to benefit if Govt accepts this demand; JLL CEO lists following demands Budget 2021 Expectations – HOME BUYERS to benefit if Govt accepts this demand; JLL CEO lists following demands
Jobs, land prices, Covid-19 vaccine, rural India, household savings, NBFCs, banks, consumption, capex - Positives and Negatives | EXPLAINED Jobs, land prices, Covid-19 vaccine, rural India, household savings, NBFCs, banks, consumption, capex - Positives and Negatives | EXPLAINED
Economy, markets, FIIs, chemicals, IT and Pharma - Make money, as India powers to new highs | EXPLAINED    Economy, markets, FIIs, chemicals, IT and Pharma - Make money, as India powers to new highs | EXPLAINED
Setback for China – Trend reversing in favour of India; SFI lands big blow! Know here WHY! Setback for China – Trend reversing in favour of India; SFI lands big blow! Know here WHY!

Swiss drugmaker Novartis is moving closer to spinning off the ailing Alcon eyecare business it bought from Nestle for $50 billion in 2010, but said on Tuesday a final decision would depend on the unit`s continued sales growth.

A 7 percent rise in Alcon sales in the third quarter pushed Novartis`s overall revenue up 2 percent to $12.4 billion, the company said, beating the $12.2 billion average in a Reuters poll of analysts.

Now, Chief Executive Joe Jimenez wants to see Alcon`s sales recovery continue before pulling the trigger on a spin off for a unit he has suggested could be worth $25-$35 billion. The unit would be sold without prescription eye drugs, which Novartis moved to its main medicines unit last year and plans to keep.

"What we would be considering right now is a separate listing," Jimenez, who on Feb. 1 will hand over the CEO job to Vas Narasimhan, told reporters on a call.

"A standalone company with a separate listing, and those shares would go to our current shareholders," he said, adding that that could happen in the first half of 2019.

Jimenez said Novartis was still reviewing potential locations for a possible Alcon listing and that proposed U.S. tax reforms -- U.S. President Donald Trump`s plan promises up to $6 trillion in cuts -- would play a role in a final decision.

In 2016, Novartis swapped out top Alcon management and began investing to reverse persistent sales declines that it has blamed on lacklustre customer service and stagnating innovation.

Investments at Alcon, including on marketing and new hires in customer support continued to bite, with the unit posting a $50 million operating loss.

Novartis shares fell 1.3 percent by 0815 GMT, which analysts said may reflect investors unhappy that an Alcon spin off will not come as early as next year.

"The timing of an expected spin/IPO may disappoint some investors that were hoping for this in 2018," Deutsche Bank analysts wrote in a note.2018 GROWTH

Novartis reported third-quarter core net income rose to $3.02 billion, compared to the average analyst estimate of $2.93 billion in a Reuters poll.

The Swiss group also confirmed its full-year outlook, with core operating income seen broadly in line or slightly declining compared with 2016 before a promised return to growth in 2018.

Novartis has been suffering through a patent expiry on its former top seller, blood cancer drug Gleevec, whose third-quarter sales plunged by nearly half to $445 million as competition from generic copies intensifies.

Meanwhile, newer psoriasis drug Cosentyx generated $556 million, up 83 percent from a year ago and beating market estimates.

Analysts said the trend looks promising.

"We continue to see the company on track to successfully exit the 2017 transition year before returning to growth in 2018," said Bruno Bulic, a Baader Helvea analyst with "buy" rating.

While sales of heart failure drug Entresto more than doubled to $128 million, they again missed market expectations amid a slowdown in July and August.

Jimenez acknowledged revenue must accelerate for Entresto to hit its 2017 target of around $500 million, though he still expects Entresto to eventually become a $5 billion-per-year medicine.

"It`s not going to be a rocket ship that has that Cosentyx-like trajectory, but it will be a steady grower and contributor to the next growth phase of the company," he said.

(This article has not been edited by Zeebiz editorial team and is auto-generated from an agency feed.)

Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.

TAGS:
Economy
RELATED NEWS
Expert Views: BIG! India's retail inflation eases to 4.59% in December Expert Views: BIG! India's retail inflation eases to 4.59% in December
Budget 2021 Expectations – HOME BUYERS to benefit if Govt accepts this demand; JLL CEO lists following demands Budget 2021 Expectations – HOME BUYERS to benefit if Govt accepts this demand; JLL CEO lists following demands
Jobs, land prices, Covid-19 vaccine, rural India, household savings, NBFCs, banks, consumption, capex - Positives and Negatives | EXPLAINED Jobs, land prices, Covid-19 vaccine, rural India, household savings, NBFCs, banks, consumption, capex - Positives and Negatives | EXPLAINED
Economy, markets, FIIs, chemicals, IT and Pharma - Make money, as India powers to new highs | EXPLAINED    Economy, markets, FIIs, chemicals, IT and Pharma - Make money, as India powers to new highs | EXPLAINED
Setback for China – Trend reversing in favour of India; SFI lands big blow! Know here WHY! Setback for China – Trend reversing in favour of India; SFI lands big blow! Know here WHY!

LATEST NEWS

Budget 2021: Tax cuts, fiscal deficit, public spending, GDP, expenditure to ARMs - what is in front of FM Nirmala Sitharaman

Farmers storm Red Fort, clashes and teargas as R-Day tractor parade turns violent

Kangana Ranaut: Indians supporting farmers' protests are ''terrorists'', should be jailed

RBI Grade B 2021 Notification News: Bumper vacancies at Reserve Bank of India! Check how to apply online at rbi.org.in

Stock Market Holidays 2021 India: Sensex, Nifty, other markets closed today for Republic Day celebration

Sonu Sood is back with yet another initiative - Check what it is and how it will help students

Salma Hayek joins the ''Bernie Sanders'' viral meme bandwagon

Budget 2021 Expectations LIVE: Check latest news, updates, demands of India Inc. here

Make in India boost, oil cess may be halved

RBI proposals to restrict land financing by NBFCs: Report

  • India News
  • World News
  • Companies News
  • Market News
  • Personal Finance News
  • Technology News
  • Automobile News
  • Small Business News
  • Income Tax Calculator
  • Live TV
  • Videos
  • Photos
  • Author
  • Rss Feed
  • Advertise with us
  • Privacy Policy
  • Legal Disclaimer

Latest Trending Updates

  • EPFO
  • Budget 2020
  • Income Tax Return
  • Auto Expo 2020
  • Home Loan
  • Business News

Trending Topics

  • Income Tax
  • income Tax Calculator
  • 7th Pay Commission
  • Reserve Bank of India
  • GST
  • Latest Business News

Follow us on

zeebiz
zeebiz

Partner Sites

  • Zee News
  • Hindi News
  • Marathi News
  • Bengali News
  • Tamil News
  • Malayalam News
  • Gujarati News
  • Telugu News
  • Kannada News
  • DNA
  • WION
Copyright © Zee Media Corporation Ltd. All rights reserved